Tavin EM 300/200mg

Tavin EM is combined with other antiviral drugs to treat HIV-1 in adults and children weighing at least 17 kg. It can also be given to at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis to lower the risk of HIV-1 infection. HIV-1 is the virus that leads to Acquired Immune Deficiency Syndrome, also known as AIDS. Tavin EM contains the prescription medicines Tenofovir, Disoproxil fumarate, and Emtricitabine. Tenofovir 300 mg belongs to a class of drugs known as nucleotide reverse transcriptase inhibitor that comes with activity against human immunodeficiency syndrome (HIV). Doctors prescribe it as a single 300/200 mg tablet once daily. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, which helps to control HIV infection. Together, they help decrease the amount of HIV in your body so your immune system can function better. This further lowers the chance of developing HIV complications (e.g., cancer or new infection) and improves the overall quality of life. The HIV drugs should be used in conjunction with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually transmitted infection HIV-1 in adults at high risk. The combination drug is also sold as Travuda.